Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

March 01, 1984; Volume 228,Issue 3

Article

  • You have access
    ERRATUM
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 809;
  • You have access
    Selective improvement in subendocardial perfusion distal to a flow-limiting coronary artery stenosis: effects of the new calcium channel blocking agent, FR 34235, nifedipine and diltiazem.
    G J Gross and D C Warltier
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 531-536;
  • You have access
    Role of sympathetic nervous system in ischemia-induced reduction of digoxin tolerance in anesthetized cats.
    D Kim, T Akera and L C Weaver
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 537-544;
  • You have access
    Antidepressant drugs with varying pharmacological profiles alter rat pineal beta adrenergic-mediated function.
    E Friedman, F D Yocca and T B Cooper
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 545-550;
  • You have access
    Dopamine analog-induced hyperglycemia in rats: involvement of the adrenal medulla and the endocrine pancreas.
    S P Arnerić, S A Chow, J P Long and L J Fischer
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 551-559;
  • You have access
    Comparison of the effects of sulindac with other cyclooxygenase inhibitors on prostaglandin excretion and renal function in normal and chronic bile duct-ligated dogs and swine.
    E J Zambraski, A N Chremos and M J Dunn
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 560-566;
  • You have access
    Org. 6368: a nondepolarizing neuromuscular blocking agent with a novel effect on end-plate conductance.
    N N Durant and R Horn
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 567-572;
  • You have access
    Effects of several aminopyridines and analogs on the calcium dependence of synaptic transmission.
    M Matsumoto and W K Riker
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 573-578;
  • You have access
    Activation of adenylate cyclase by alcohols requires the nucleotide-binding protein.
    G R Luthin and B Tabakoff
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 579-587;
  • You have access
    Relationship between N-acetylator phenotype and susceptibility toward hydrazine-induced lethal central nervous system toxicity in the rabbit.
    D W Hein and W W Weber
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 588-592;
  • You have access
    Fenfluramine, p-chloroamphetamine and p-fluoroamphetamine stimulation of pituitary-adrenocortical activity in rat: evidence for differences in site and mechanism of action.
    J F McElroy, J M Miller and J S Meyer
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 593-599;
  • You have access
    Fragment C of tetanus toxin antagonizes the neuromuscular blocking properties of native tetanus toxin.
    L L Simpson
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 600-604;
  • You have access
    Influence of genetic polymorphism on the metabolism and disposition of encainide in man.
    T Wang, D M Roden, H T Wolfenden, R L Woosley, A J Wood and G R Wilkinson
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 605-611;
  • You have access
    Sensitivity and responsiveness of tracheal and bronchial tissues from young and old guinea pigs: effect of calcium antagonists.
    P G Duncan and J S Douglas
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 612-619;
  • You have access
    Modification of kindled amygdaloid seizures by opiate agonists and antagonists.
    T E Albertson, R M Joy and L G Stark
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 620-627;
  • You have access
    Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites.
    R L Friedman, R J Barrett and E Sanders-Bush
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 628-635;
  • You have access
    Greater potency of mesoridazine and sulforidazine compared with the parent compound, thioridazine, on striatal dopamine autoreceptors.
    D M Niedzwiecki, R B Mailman and L X Cubeddu
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 636-639;
  • You have access
    Agonist interactions with beta adrenergic receptors in rat brain.
    J M O'Donnell, B B Wolfe and A Frazer
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 640-647;
  • You have access
    Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
    G R Luthin and B B Wolfe
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 648-655;
  • You have access
    Physostigmine inhibition of 3',5'-cyclic AMP phosphodiesterase from cat sciatic nerve.
    W H Curley, F G Standaert and K L Dretchen
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 656-661;
  • You have access
    4-Keto niridazole: a major niridazole metabolite with central nervous system toxicity different than niridazole.
    B A Catto, C I Valencia, K Hafez, E H Fairchild and L T Webster
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 662-668;
  • You have access
    Effects of naloxone, diprenorphine, buprenorphine and etorphine on unpunished and punished food-reinforced responding in the squirrel monkey.
    S E DeRossett and S G Holtzman
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 669-675;
  • You have access
    Biological evaluation of some ionophore-polymeric chelator combinations for reducing iron overload.
    C A Tyson, S E LeValley, R Chan, P D Hobbs and M I Dawson
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 676-681;
  • You have access
    Association between cyclic GMP accumulation and acetylcholine-elicited relaxation of bovine intrapulmonary artery.
    L J Ignarro, T M Burke, K S Wood, M S Wolin and P J Kadowitz
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 682-690;
  • You have access
    Behavior maintained under fixed-interval and second-order schedules by intravenous injections of endogenous noncatecholic phenylethylamines in dogs.
    H E Shannon and W A Thompson
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 691-695;
  • You have access
    Characterization of the neurogenic vasodilatation elicited by central dopamine receptor stimulation with pergolide.
    M F Lokhandwala, S D Kivlighn and B S Jandhyala
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 696-703;
  • You have access
    Evidence for an alpha-1 receptor-mediated central sympathoinhibitory action of ketanserin.
    R B McCall and M R Schuette
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 704-710;
  • You have access
    Effects of nifedipine on total cardiac output distribution in conscious rat.
    K Kanda and S F Flaim
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 711-718;
  • You have access
    Central nervous system site of action of capsaicin-induced cardiovascular changes in the cat.
    J A Quest, J Dias-Souza, W P Norman, J R Holtman and R A Gillis
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 719-724;
  • You have access
    Evidence that exogenous but not endogenous norepinephrine activates the presynaptic alpha-2 adrenoceptors on serotonergic nerve endings in the rat hypothalamus.
    A M Galzin, C Moret and S Z Langer
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 725-732;
  • You have access
    Beta-1 and beta-2 adrenoceptor-mediated responses in preparations of pulmonary artery and aorta from young and aged rats.
    S R O'Donnell and J C Wanstall
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 733-738;
  • You have access
    A study of the selectivity and potency of rauwolscine, RX 781094 and RS 21361 as antagonists of alpha-1 and alpha-2 adrenoceptors.
    P B Timmermans, J Q Qian, R R Ruffolo and P A van Zwieten
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 739-748;
  • You have access
    Evidence for the direct effect of vasopressin on human and goat cerebral arteries.
    S Lluch, M V Conde, G Diéguez, A L López de Pablo, M C González, C Estrada and B Gómez
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 749-755;
  • You have access
    Mode of action of ciguatoxin from the Spanish Mackerel, Scomberomorus commersoni, on the guinea-pig ileum and vas deferens.
    R J Lewis and R Endean
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 756-760;
  • You have access
    Comparative effects of calcium channel blocking agents and varying extracellular calcium concentration on hypoxia/reoxygenation and ischemia/reperfusion-induced cardiac injury.
    D B Fitzpatrick and M Karmazyn
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 761-768;
  • You have access
    Radioisomers of scoparone (6,7-dimethoxycoumarin) as a tool for in vivo differentiation of various hepatic monooxygenase inducers in mice using the breath test technique.
    W Legrum, L Kling and E Funke
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 769-773;
  • You have access
    Comparison of different clearance estimates for metoprolol in the rhesus monkey.
    A Rane, S Högstedt, B Lindberg, C G Regårdh and H Jorulf
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 774-778;
  • You have access
    Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
    I Cavero, F Lefevre-Borg, F Lhoste, C Sabatier, C Richer and J F Giudicelli
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 779-791;
  • You have access
    Adenosine attenuation of the electrophysiological effects of isoproterenol on canine cardiac Purkinje fibers.
    D P Rardon and J C Bailey
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 792-798;
  • You have access
    Acute effects of alkylating agents on canine renal function and ultrastructure: high-dose ethacrynic acid vs. dihydroethacrynic acid and ticrynafen.
    D A Koechel, G C Budd and N S Bretz
    Journal of Pharmacology and Experimental Therapeutics March 1984, 228 (3) 799-809;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 228, Issue 3
1 Mar 1984
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Article
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • Ocular Drug Delivery: Past, Present, and Future
  • Rho GTPase–Pathway Inhibitor Reduces Markers of Fibrosis
  • Nose-to-Brain Delivery
  • Stem Cells Therapies in AD
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics